SE0100478D0 - Novel formulation - Google Patents

Novel formulation

Info

Publication number
SE0100478D0
SE0100478D0 SE0100478A SE0100478A SE0100478D0 SE 0100478 D0 SE0100478 D0 SE 0100478D0 SE 0100478 A SE0100478 A SE 0100478A SE 0100478 A SE0100478 A SE 0100478A SE 0100478 D0 SE0100478 D0 SE 0100478D0
Authority
SE
Sweden
Prior art keywords
novel formulation
formulation
novel
Prior art date
Application number
SE0100478A
Other languages
English (en)
Inventor
Anne Juppo
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0100478A priority Critical patent/SE0100478D0/sv
Publication of SE0100478D0 publication Critical patent/SE0100478D0/sv
Priority to SI200230343T priority patent/SI1368006T1/sl
Priority to JP2002563914A priority patent/JP2004518708A/ja
Priority to PCT/SE2002/000227 priority patent/WO2002064118A1/en
Priority to KR10-2003-7010577A priority patent/KR20040058103A/ko
Priority to PT02710645T priority patent/PT1368006E/pt
Priority to DE60211130T priority patent/DE60211130T2/de
Priority to AT02710645T priority patent/ATE324871T1/de
Priority to CNA028049063A priority patent/CN1491105A/zh
Priority to BR0206825-7A priority patent/BR0206825A/pt
Priority to ES02710645T priority patent/ES2261643T3/es
Priority to DK02710645T priority patent/DK1368006T3/da
Priority to PCT/SE2002/000228 priority patent/WO2002064121A1/en
Priority to EP02710645A priority patent/EP1368006B1/en
Priority to AU2002228579A priority patent/AU2002228579B2/en
Priority to NZ526993A priority patent/NZ526993A/en
Priority to CA002434835A priority patent/CA2434835A1/en
Priority to NZ526994A priority patent/NZ526994A/en
Priority to EP02711597A priority patent/EP1361868A1/en
Priority to MXPA03007092A priority patent/MXPA03007092A/es
Priority to US10/467,723 priority patent/US20040067252A1/en
Priority to IL15707502A priority patent/IL157075A0/xx
Priority to CNA028049144A priority patent/CN1491104A/zh
Priority to CA002434542A priority patent/CA2434542A1/en
Priority to US10/467,900 priority patent/US20040067256A1/en
Priority to JP2002563916A priority patent/JP2004518709A/ja
Priority to ZA200305944A priority patent/ZA200305944B/xx
Priority to NO20033564A priority patent/NO20033564L/no
Priority to HK04102657A priority patent/HK1059740A1/xx
Priority to US11/748,366 priority patent/US20080118560A1/en

Links

SE0100478A 2001-02-13 2001-02-13 Novel formulation SE0100478D0 (sv)

Priority Applications (30)

Application Number Priority Date Filing Date Title
SE0100478A SE0100478D0 (sv) 2001-02-13 2001-02-13 Novel formulation
JP2002563916A JP2004518709A (ja) 2001-02-13 2002-02-08 新規放出修飾製剤
AU2002228579A AU2002228579B2 (en) 2001-02-13 2002-02-08 Novel modified released formulation
CA002434835A CA2434835A1 (en) 2001-02-13 2002-02-08 Novel modified released formulation
NZ526993A NZ526993A (en) 2001-02-13 2002-02-08 Pharmaceutical formulation of a drug substance that has a pH-dependent solubility in water
KR10-2003-7010577A KR20040058103A (ko) 2001-02-13 2002-02-08 신규 개질 방출 제제
JP2002563914A JP2004518708A (ja) 2001-02-13 2002-02-08 放出性が改良された新規な処方物
DE60211130T DE60211130T2 (de) 2001-02-13 2002-02-08 Neue formulierung mit modifizierter freisetzung
AT02710645T ATE324871T1 (de) 2001-02-13 2002-02-08 Neue formulierung mit modifizierter freisetzung
CNA028049063A CN1491105A (zh) 2001-02-13 2002-02-08 新的改进释放的制剂
BR0206825-7A BR0206825A (pt) 2001-02-13 2002-02-08 Formulação de dispersão sólida de liberação modificada, multiparticulada, processo para a preparação da formulação, uso da mesma, tablete, e, métodos para o tratamento de uma doença cardiovascular, e, para o tratamento de câncer
ES02710645T ES2261643T3 (es) 2001-02-13 2002-02-08 Nueva formulacion de liberacion modificada.
DK02710645T DK1368006T3 (da) 2001-02-13 2002-02-08 Hidtil ukendt formulering med modificeret frigivelse
NZ526994A NZ526994A (en) 2001-02-13 2002-02-08 Novel modified released formulation
EP02710645A EP1368006B1 (en) 2001-02-13 2002-02-08 Novel modified released formulation
SI200230343T SI1368006T1 (sl) 2001-02-13 2002-02-08 Nova formulacija z modificiranim sproscanjem
PCT/SE2002/000227 WO2002064118A1 (en) 2001-02-13 2002-02-08 Novel modified release formulation
PT02710645T PT1368006E (pt) 2001-02-13 2002-02-08 Nova formulacao de libertacao modificada
PCT/SE2002/000228 WO2002064121A1 (en) 2001-02-13 2002-02-08 Novel modified released formulation
EP02711597A EP1361868A1 (en) 2001-02-13 2002-02-08 Novel modified release formulation
MXPA03007092A MXPA03007092A (es) 2001-02-13 2002-02-08 Nueva formulacion de liberacion modificada.
US10/467,723 US20040067252A1 (en) 2001-02-13 2002-02-08 Novel modified release formulation
IL15707502A IL157075A0 (en) 2001-02-13 2002-02-08 Novel modified release formulation
CNA028049144A CN1491104A (zh) 2001-02-13 2002-02-08 新型改进释放制剂
CA002434542A CA2434542A1 (en) 2001-02-13 2002-02-08 Novel modified release formulation
US10/467,900 US20040067256A1 (en) 2001-02-13 2002-02-08 Novel modified release formulation
ZA200305944A ZA200305944B (en) 2001-02-13 2003-07-31 Novel modified release formulation.
NO20033564A NO20033564L (no) 2001-02-13 2003-08-12 Ny formulering med modifisert frigivningsvirkning
HK04102657A HK1059740A1 (en) 2001-02-13 2004-04-15 Novel modified released formulation
US11/748,366 US20080118560A1 (en) 2001-02-13 2007-05-14 Novel modified release formulation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0100478A SE0100478D0 (sv) 2001-02-13 2001-02-13 Novel formulation

Publications (1)

Publication Number Publication Date
SE0100478D0 true SE0100478D0 (sv) 2001-02-13

Family

ID=20282968

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0100478A SE0100478D0 (sv) 2001-02-13 2001-02-13 Novel formulation

Country Status (2)

Country Link
SE (1) SE0100478D0 (sv)
ZA (1) ZA200305944B (sv)

Also Published As

Publication number Publication date
ZA200305944B (en) 2005-05-25

Similar Documents

Publication Publication Date Title
DE50204184D1 (de) Espressobrüheinrichtung
ATE524462T1 (de) C5-modifizierte indazolylpyrrolotriazine
IS6915A (is) Lyfjablanda
BR0210619A (pt) composição
DE50103741D1 (de) Welle-Nabe-Verbindung
DE50204386D1 (de) Kreuztransducer
IS7081A (is) Lyfjablanda
ATE335486T1 (de) Hydrazono-malonitrile
DE50204551D1 (de) Kugelgelenk
DE50203412D1 (de) Schwenkkolbenverdränger
DE50203984D1 (de) Kugelgelenk
ATE355059T1 (de) Isoxazolopyridinone
DE50201862D1 (de) Messwandler
ATE369137T1 (de) Lyophilisierte formulierung enthaltend olanzapin
DE50203093D1 (de) Losradlager
ATE319694T1 (de) Phenylalkyne
ATA18372001A (de) Gelenksbolzenbaueinheit
ITTO20020747A0 (it) Composizione
DE50202088D1 (de) Garmodulsystem
ATA13992002A (de) Schlackengranulierungsanlage
ITTO20020745A0 (it) Composizione
DE10295006D2 (de) Bauwerksabdichtung
DE50108381D1 (de) Synchronisierschaltungsanordnung
AT500276B8 (de) Radschwenksystem
ATE345337T1 (de) Delta1 -pyrroline